PharVision Advisers’s Titan International TWI Stock Holding History

PharVision Advisers’s Portfolio TWI Stock Details TWI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,936	Closed	-$173K	–	1014
2025 Q3	$173K	Buy	+22,936	New	+$205K	0.1%	547

Other funds holding TWI

AIP LLC New York $95.2M AUM 36.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.65B AUM 47.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JAFL

Jay A. Fishman Ltd Troy, Michigan $1.26B AUM 31.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PharVision Advisers's TWI Position: Q4 2025 in Review

PharVision Advisers sold out of Titan International (TWI) in Q4 2025, closing a stake of 22,936 shares — an estimated $173K sold.

PharVision Advisers first reported a position in TWI in Q3 2025 and held it in 1 quarter. The position peaked at $173K in Q3 2025. 179 funds tracked by Wall St. Rank hold TWI as of Q4 2025.

PharVision Advisers reported no remaining Titan International position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 22,936 Titan International shares in Q4 2025, an estimated $173K.
PharVision Advisers first reported a position in Titan International in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Titan International position peaked at $173K in Q3 2025.
179 funds tracked by Wall St. Rank held Titan International as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.